Clinical Outcome and Toxicity Profiles of Patients with EGFR-mutation Positive Non-Small-Cell Lung Cancer

被引：0
|
作者：
Munawar, K. [1 ]
Sheikh, H. [1 ]
机构：
[1] Shaukat Khanum Mem Canc Hosp, Lahore, Pakistan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 03期
关键词：
EGFR mutation; EGFR-TKI; Lung cancer;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P76.75
引用
收藏
页码：S621 / S622
页数：2
相关论文
共 50 条
  • [31] The predictive value of uncommon EGFR mutation in patients with non-small-cell lung cancer.
    Tu, Haiyan
    Ke, Ee
    Sun, Yue-Li
    Zheng, Ming-Ying
    Yang, Jin-Ji
    Wang, Zhen
    Wu, Si-Pei
    Su, Jian
    Zhang, Xuchao
    Bai, Xiao-Yan
    Yang, Xue-Ning
    Zhong, Wenzhao
    Yan, Hong-Hong
    Zhou, Qing
    Wu, Yi-Long
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [32] Concomitant EGFR Mutation and ALK Rearrangement in Non-Small-Cell Lung Cancer
    Chen, R.
    Zhang, X.
    Wu, Y.
    Chen, H.
    Zhou, Q.
    Su, J.
    Tu, H.
    Xie, Z.
    Zhong, W.
    Yang, J.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2225 - S2226
  • [33] Metastatic non-small-cell lung cancer with EGFR mutation - case report
    Jasiowka, Marek
    Cedrych, Ida
    [J]. ONCOLOGY IN CLINICAL PRACTICE, 2014, 10 : G46 - G48
  • [34] Clinical benefit of second EGFR-TKI retreatment on overall survival in patients with advanced non-small-cell lung cancer harboring EGFR-mutation positive after failure of the initial EGFR-TKI treatment: A retrospective analysis.
    Nakashima, Masanao
    Hirose, Takashi
    Oki, Yasunari
    Murata, Yasunori
    Sugiyama, Tomohide
    Ishida, Hiroo
    Okuda, Kentaro
    Yamaoka, Toshimitsu
    Ohmori, Tohru
    Ohnishi, Tsukasa
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [35] EGFR mutation and non-small-cell lung cancer: EGFR test, cost and quality of life
    Thongprasert, Sumitra
    [J]. LUNG CANCER MANAGEMENT, 2012, 1 (03) : 169 - 172
  • [36] Nivolumab for Patients with EGFR Mutation-Positive Non-Small Cell Lung Cancer
    Yoshida, H.
    Kim, Y. H.
    Ozasa, H.
    Nagai, H.
    Sakamori, Y.
    Tsuji, T.
    Nomizo, T.
    Funazo, T.
    Yasuda, Y.
    Hirai, T.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2416 - S2416
  • [37] Analysis of Survival in EGFR-Mutation-Positive Advanced Non-Small-Cell Lung Cancer Patients with Miliary Pulmonary Metastasis
    Watanabe, Kageaki
    Okuma, Yusuke
    Miwa, Maki
    Hosomi, Yukio
    Okamura, Tatsuru
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1228 - S1229
  • [38] Biopsy on progression in patients with EGFR mutation-positive advanced non-small-cell lung cancer-a Canadian experience
    Chu, Q.
    Agha, A.
    Devost, N.
    Walton, R. N.
    Ghosh, S.
    Ho, C.
    [J]. CURRENT ONCOLOGY, 2020, 27 (01) : 27 - 33
  • [39] Sequential treatment with afatinib and osimertinib in patients with EGFR mutation-positive non-small-cell lung cancer: an observational study
    Hochmair, Maximilian J.
    Morabito, Alessandro
    Hao, Desiree
    Yang, Cheng-Ta
    Soo, Ross A.
    Yang, James C-H
    Gucalp, Rasim
    Halmos, Balazs
    Wang, Lara
    Golembesky, Amanda
    Maerten, Angela
    Cufer, Tanja
    [J]. FUTURE ONCOLOGY, 2018, 14 (27) : 2861 - 2874
  • [40] EGFR tyrosine kinase inhibitors for EGFR mutation-positive non-small-cell lung cancer: outcomes in Asian populations
    Kim, Edward S.
    Melosky, Barbara
    Park, Keunchil
    Yamamoto, Nobuyuki
    Yang, James C-H
    [J]. FUTURE ONCOLOGY, 2021, 17 (18) : 2395 - 2408
12345